Background Image
Table of Contents Table of Contents
Previous Page  397 / 658 Next Page
Information
Show Menu
Previous Page 397 / 658 Next Page
Page Background

5

Thermo Scientific Poster Note

PN64231-EN 1114S

For forensic use o

All trademarks are the proper

This information is not intend

intellectual property rights of

ay precision for the lowest QC

0 ng/mL according to LOQ.

ention time.

Conclusion

We developed

compounds in

Method meets

Matrix effects

standards are

Short 3.8 minu

throughput on

Analysis of TH

were evaluate

LOQ was not a

Analyte

LOQ

(ng/ml)

Precision

%RSD (n=5)

razolam

2

10.2

rfentanyl

5

14.3

pentadol

2

4.82

zepam

20

5.47

madol

5

5.81

henhydramine

2

3.72

prenorphine

20

9.27

lpidem

1

1.81

xepin

20

10.3

loxetine

20

5.46

ntanyl

1

4.90

xtromethorphan

2

5.69

clobenzaprine

2

5.40

sipramine

50

3.98

rtriptyline

2

6.24

triptyline

50

13.3

ipramine

10

7.28

itriptyline

5

4.63

P

1

2.47

DP

2

3.49

mipramine

10

4.33

mipramine

50

3.66

thadone

2

1.99

Analyte

%Rec

Analyte

%Rec

Morphine-d3

64.3

Alprazolam-d5

83.8

Nicotine-d4

90.2

Norfentanyl-d5

90.7

Zonisamide-13C6

102

Tapentadol-d3

88.7

Oxymorphone-d3

85.7

Diazepam-d5

83.2

Hydromorphone-d6

78.3

Tramadol-d3

89.6

7-Aminoclonazepam-d4

62.9

Diphenhydramine-d3

92.2

Meprobamate-d7

94.5

Buprenorphine-d4

99.1

Benzoylecgonine-d3

78.4

Zolpidem-d6

107

Codeine

92.2

Doxepin-d3

95.2

Pregabalin-d6

105

Duloxetine-d3

82.1

6-MAM-d3

97.3

Fentanyl-d5

104

Noroxycodone-d3

84.4

Dextromethorphan-d3

99.3

Oxycodone-d3

85.4

Cyclobenzaprine-d3

97.4

Norhydrocodone-d3

83.4

Desipramine-d3

97.9

Hydrocodone-d6

83.8

Nortriptyline-d3

101

Amphetamine-d3

72.7

Protriptyline-d3

95.9

Carisoprodol-d7

92.9

Imipramine-d3

99.5

Lorazepam-d4

Not used

Amitriptyline-d3

105

a-Hydroxyalprazolam-d5

98.8

PCP-d5

102

Methamphetamine-d5

88.6

EDDP-d3

107

MDMA-d5

89.9

Trimipramine-d3

101

Temazepam-d5

95.0

Clomipramine-d3

98.4

Clonazepam-d4

89.4

Methadone-d3

100

Nordiazepam-d5

87.9

Table 4. Matrix effects: Mean internal standard %Recovery for 50 donor urine

samples.

e

Figure 2. Matrix effects: Internal standard %Recovery in 50 donor samples for

some of the least and the most affected analytes.

0

20

40

60

80

100

120

140

S1

S3

S5

S7

S9

S11

S13

S15

S17

S19

S21

S23

S25

S27

S29

S31

S33

S35

S37

S39

S41

S43

S45

S47

S49

6-MAM-d3

OH_Alprazolam-d5

Amitriptyline-d5

Benzoylecgonine-d3

carisoprodol-d7

Codeine-d3

Cyclobenzap-d3

Figure 3. Chromatograms from donor urine samples. Chromatograms selected

are those with lowest analyzed concentration for a given compound.

Fentanyl 64.6 ng/mL

Norfentanyl 675 ng/mL

Zolpidem 9.8 ng/mL

Morphine 207 ng/mL

Figure 4. The method e

system: one injection ev

5 ng/mL

2 ng/mL

Figure 3. (continued)